DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy

Photo: HealthVetted editorial render
GLP-1 receptor agonist

Photo: HealthVetted editorial render
Urolithin A (Mitopure), 500 mg/day
| # | Product | Active ingredient | Starting price | FDA status | Score | |
|---|---|---|---|---|---|---|
| 1 | Thorne | — | Best ·$25/mo | supplement | Top ·7.8 | See offer → |
| 2 | Timeline Mitopure (Urolithin A) | Urolithin A (Mitopure), 500 mg/day | $95/mo | supplement | 7.3 | See offer → |
Thorne's longevity line centers on raising NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential for mitochondrial energy production and DNA repair that declines with age. ResveraCel delivers nicotinamide riboside (NR), a vitamin B3 form the body converts into NAD+, which in turn fuels "sirtuin" enzymes linked to cellular maintenance. The formula adds trans-resveratrol and quercetin phytosome (intended to support sirtuin activity and absorption) plus betaine to support methylation, since NAD+ metabolism consumes methyl groups. In plain terms: NR is the raw material that tops up your NAD+ tank; the other ingredients are meant to help that tank get used efficiently. This is a plausible mechanism, but a mechanism is not the same as a proven health outcome.
Urolithin A is a metabolite your gut bacteria make from ellagitannins in pomegranate and berries, though many people produce little of it. Each 500 mg daily dose of Mitopure delivers a standardized, bioavailable form that triggers mitophagy, the cellular process of recycling damaged mitochondria, which helps muscle cells preserve mitochondrial quality and energy output as they age.
The strongest evidence is narrow but consistent: NR reliably raises NAD+. A randomized, double-blind, placebo-controlled trial of 120 adults aged 60-80 testing an NR-plus-pterostilbene formula found whole-blood NAD+ rose roughly 40% at the recommended dose and about 90% at double dose by week 4, sustained over the 8-week trial (Dellinger et al., npj Aging, 2017). A 2025 eClinicalMedicine long-COVID trial using 2000 mg/day NR raised NAD+ about 2.6-3.1 fold, yet showed no statistically significant improvement in its primary cognition outcome or in fatigue, sleep, or mood versus placebo; exploratory analyses hinted at some symptom improvement in those who took NR for at least 10 weeks, but this was not a confirmed result. Resveratrol's longevity benefits remain unproven in humans: comprehensive reviews cite poor bioavailability and no conclusive clinical evidence for anti-aging outcomes. So: NAD+ goes up; downstream "live longer/feel younger" benefits are not yet demonstrated.
Randomized, double-blind, placebo-controlled trials published in Cell Reports Medicine (2022, middle-aged adults) and JAMA Network Open (2022, older adults) found that 500 mg/day Urolithin A improved muscle strength (around 12% in one trial), exercise endurance, and biomarkers of mitochondrial health versus placebo. The evidence is strongest for muscle and mitochondrial function; it does not demonstrate extended lifespan in humans.
In clinical trials, NR-based formulas were well tolerated with no serious adverse events; mild, uncommon effects included gastrointestinal upset (nausea, bloating), more frequent at higher doses. Resveratrol at high doses can cause GI symptoms and, because it may mildly inhibit platelet aggregation and certain drug-metabolizing enzymes, can theoretically increase bleeding or interact with medications. Quercetin is generally well tolerated. There are no documented serious safety signals at label doses, but long-term, high-dose safety data are limited, so periodic check-ins with a clinician are sensible. This is general information, not medical advice.
Across 25+ human studies Mitopure has shown a strong safety profile and holds FDA GRAS status. Infrequent effects can include mild digestive discomfort or nausea. Stop and consult a clinician if you experience an unexpected reaction.
As of 2026, ResveraCel runs about $58-60 for a one-month supply (60 capsules at the standard 2-capsules-once-daily serving), with roughly 10% off via Thorne's subscription. Third-party retailers (Amazon, iHerb, Vitacost, and the Mayo Clinic Store) price it similarly, occasionally a few dollars less. Supplements are not covered by insurance, but US buyers can typically pay with HSA/FSA funds. Thorne's separate Biological Age test is about $95, and note that the required blood panel is an added, separate cost you arrange yourself.
As of 2026, roughly $85-$95/month on longer subscriptions, $112.50/month on a basic monthly plan, or $125 for a one-time 30-day softgel bottle from Timeline. Powder and gummy formats are also sold. Not covered by insurance.
Best for generally healthy adults, often 40+, who want a high-purity NAD+ precursor and value third-party certification (athletes benefit from NSF Certified for Sport options). Avoid or get medical clearance if you are pregnant or breastfeeding, have liver or kidney disease, or take blood thinners or blood-pressure medication, since resveratrol can affect clotting and drug metabolism. People on chemotherapy or with hormone-sensitive conditions should consult an oncologist before using resveratrol-containing products. It is a supplement, not a treatment for any diagnosed disease.
Marketed to healthy adults, particularly those focused on muscle and mitochondrial health with age. Not intended for those pregnant or breastfeeding; consult a clinician if you have a medical condition or take medications. This is educational information, not medical advice.
Timeline Mitopure (Urolithin A): Mitopure is the most clinically validated product in the longevity supplement aisle, with several randomized trials on the exact compound. It is also one of the most expensive, and the proven benefits are about muscle and mitochondrial function, not extending lifespan. On balance, Thorne edges ahead in our scoring, but the right choice depends on your situation.
Editorial comparison, not medical advice. Discuss options with a qualified clinician. Individual results vary.